Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 726,527 shares of the healthcare conglomerate's stock, valued at approximately $367,521,000. UnitedHealth Group makes up approximately 0.7% of Universal Beteiligungs und Servicegesellschaft mbH's holdings, making the stock its 17th largest position. Universal Beteiligungs und Servicegesellschaft mbH owned 0.08% of UnitedHealth Group at the end of the most recent quarter.
Other institutional investors also recently modified their holdings of the company. Western Pacific Wealth Management LP grew its position in shares of UnitedHealth Group by 2.2% in the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate's stock valued at $456,000 after purchasing an additional 19 shares in the last quarter. Axiom Financial Strategies LLC grew its holdings in UnitedHealth Group by 3.6% in the 4th quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate's stock valued at $291,000 after buying an additional 20 shares in the last quarter. Richwood Investment Advisors LLC boosted its position in shares of UnitedHealth Group by 0.4% during the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock valued at $2,654,000 after acquiring an additional 20 shares during the last quarter. Prentice Wealth Management LLC increased its position in UnitedHealth Group by 0.8% during the fourth quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate's stock worth $1,278,000 after purchasing an additional 21 shares during the last quarter. Finally, 44 Wealth Management LLC boosted its holdings in UnitedHealth Group by 1.6% in the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate's stock valued at $662,000 after purchasing an additional 21 shares during the last quarter. 87.86% of the stock is owned by institutional investors.
Insider Activity
In other news, Director Kristen Gil acquired 3,700 shares of the business's stock in a transaction that occurred on Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the acquisition, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Stephen J. Hemsley acquired 86,700 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The stock was acquired at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the purchase, the chief executive officer now owns 679,493 shares in the company, valued at $196,081,295.01. The trade was a 14.63% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 109,408 shares of company stock worth $31,607,768 in the last 90 days. Company insiders own 0.33% of the company's stock.
UnitedHealth Group Price Performance
NYSE:UNH traded down $1.60 during midday trading on Thursday, hitting $296.52. 10,880,231 shares of the stock were exchanged, compared to its average volume of 6,725,792. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The company has a market capitalization of $268.98 billion, a price-to-earnings ratio of 19.13, a P/E/G ratio of 1.37 and a beta of 0.56. The business has a 50-day moving average price of $439.50 and a two-hundred day moving average price of $498.65. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter last year, the firm posted $6.91 EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
Analyst Upgrades and Downgrades
UNH has been the topic of a number of research analyst reports. Truist Financial restated a "buy" rating and issued a $360.00 target price (down previously from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. KeyCorp lowered their target price on shares of UnitedHealth Group from $575.00 to $450.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. Wolfe Research decreased their price objective on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a report on Tuesday, May 20th. Erste Group Bank lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Finally, Barclays dropped their price objective on UnitedHealth Group from $513.00 to $362.00 and set an "overweight" rating for the company in a research note on Thursday, May 15th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group presently has an average rating of "Moderate Buy" and an average price target of $441.87.
View Our Latest Research Report on UnitedHealth Group
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.